Colorectal cancer (Q57191694)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24225001%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24225001%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24225001%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Matthias Kloor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24225001%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Christian Peter Pox

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24225001%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

11 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24225001%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24225001%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24225001%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

9927

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24225001%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

1490-1502

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24225001%20AND%20SRC:MED&resulttype=core&format=json

Cancer treatment and survivorship statistics, 2012

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Worldwide variations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

International trends in colorectal cancer incidence rates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Subsite-specific colorectal cancer risk in the colorectal endoscopy era.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Recent trends in colorectal cancer mortality in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Trends in cancer mortality in China: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Cancer survival in Africa, Asia, and Central America: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Population-based family history-specific risks for colorectal cancer: a constellation approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Obesity and risk of colorectal cancer: a systematic review of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Helicobacter pylori is a risk factor for colonic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Genomic analysis identifies association of Fusobacterium with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

The effect of estrogen vs. combined estrogen‐progestogen therapy on the risk of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Aspirin and cancer risk: a quantitative review to 2011.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Protection from colorectal cancer after colonoscopy: a population-based, case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Statins and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Characterization of gene-environment interactions for colorectal cancer susceptibility loci

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

A colorectal cancer classification system that associates cellular phenotype and responses to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Classification of colorectal cancer based on correlation of clinical, morphological and molecular features

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Molecular Genetics of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Genetic instability in colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

The serrated pathway to colorectal carcinoma: current concepts and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Hereditary and familial colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Antioncogenes and human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Diagnosing Lynch syndrome: is the answer in the mouth?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Microsatellite instability in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Colorectal cancer and genetic alterations in the Wnt pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Clinico-pathologic Parameters for Prediction of Microsatellite Instability in Colorectal Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Systematic review of microsatellite instability and colorectal cancer prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Cancer classification using the Immunoscore: a worldwide task force

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Targeted therapy in metastatic colorectal cancer -- an example of personalised medicine in action.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Synchronous carcinoma of the colon and rectum: prognostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

CT colonography for detection and characterisation of synchronous proximal colonic lesions in patients with stenosing colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

How good is endoscopic ultrasound in differentiating various T stages of rectal cancer? Meta-analysis and systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Can endoscopic ultrasound predict early rectal cancers that can be resected endoscopically? A meta-analysis and systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

MR imaging for preoperative evaluation of primary rectal cancer: practical considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Rectal cancer: primary staging and assessment after chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Diagnostic accuracy of computed tomography for colon cancer staging: A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Diagnostic Imaging of Colorectal Liver Metastases with CT, MR Imaging, FDG PET, and/or FDG PET/CT: A Meta-Analysis of Prospective Studies Including Patients Who Have Not Previously Undergone Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

The impact of intraoperative ultrasonography on the surgical treatment of patients with colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Contrast-enhanced ultrasound vs multidetector-computed tomography for detecting liver metastases in colorectal cancer: a prospective, blinded, patient-by-patient analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Preoperative chest computerized tomography in patients with locally advanced mid or lower rectal cancer: its role in staging and impact on treatment strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Rectal cancer: incidence of pulmonary metastases on thoracic CT and correlation with T staging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Improving patient survival with the colorectal cancer multi-disciplinary team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Result of the implementation of multidisciplinary teams in rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Recurrence and survival after total mesorectal excision for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

What is the role for the circumferential margin in the modern treatment of rectal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Prognostic factors after surgery for locally recurrent rectal cancer: an overview.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Long-term results of laparoscopic colorectal cancer resection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Laparoscopic versus open colorectal resection for cancer: a meta-analysis of results of randomized controlled trials on recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Laparoscopic vs open resection for rectal cancer: a meta-analysis of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Robotic resection compared with laparoscopic rectal resection for cancer: systematic review and meta-analysis of short-term outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Neoadjuvant short- or long-term radio(chemo)therapy for rectal cancer: how and who should be treated?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Targeted treatments in colorectal cancer: state of the art and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

In the era of widespread endoscopy use, randomized trials may strongly underestimate the effects of colorectal cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Cost-effectiveness of colorectal cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Next-generation stool DNA test accurately detects colorectal cancer and large adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Screening for colorectal cancer: a guidance statement from the American College of Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Organized colorectal cancer screening in integrated health care systems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon Cancer Family Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Meat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961649-9

7 January 2021

10.1016/S0140-6736(13)61649-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24225001%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24225001%20AND%20SRC:MED&resulttype=core&format=json